GSA Capital Partners’s Biomerica BMRA Stock Holding History

GSA Capital Partners’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,073	Closed	-$419K	–	1436
2021 Q2	$419K	Buy	+13,073	New	+$443K	0.05%	740

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fore Capital New York $162M AUM 14.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

GSA Capital Partners's BMRA Position: Q3 2021 in Review

GSA Capital Partners sold out of Biomerica (BMRA) in Q3 2021, closing a stake of 13,073 shares — an estimated $419K sold.

GSA Capital Partners first reported a position in BMRA in Q2 2021 and held it in 1 quarter. The position peaked at $419K in Q2 2021. 22 funds tracked by Wall St. Rank hold BMRA as of Q3 2021.

GSA Capital Partners reported no remaining Biomerica position as of Q3 2021 after selling out during the quarter.
GSA Capital Partners sold 13,073 Biomerica shares in Q3 2021, an estimated $419K.
GSA Capital Partners first reported a position in Biomerica in Q2 2021 and held it in 1 quarter.
GSA Capital Partners's Biomerica position peaked at $419K in Q2 2021.
22 funds tracked by Wall St. Rank held Biomerica as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.